Subject index volume 111 (1997)

ELSEVIER

Cancer

Letters

11 I (I 997) 247-250

Subject index Volume 111 ( 1997)

a-Tocopherol hemisuccinate; MCF-7; MCF- IOA; Breast epithelial cells: Cholesteryl hemisuccinate 111, I33

APC; PCR-SSCP; Point mutations; fiemizygous deletion 111, 7 1

(12 MWLKP; 111, 149

Apoptosis; Chemotherapeutic enzymes: Genes 111,225

Flow

cytometry;

Calibration

beads; Tumour

cells

(C3HxMSM)Fl mouse; Forestomach; Squamous cell carcinoma: H-rcls; ~53; N-Methyl-N-nitrosourea (MNU) 111, 97

ATX-SlO: 111.21s

2-Acetylaminotluorene: Cancer promotion

Basic FGF;

EGF 111, 149

receptor:

Hepatocarcinogcnesis;

Breast 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone hacco; Carcinogenesis; Mink: 111.167 A&;

MeIQx;

Aberrant

crypt

(NNK); WNitrosonomicotine

foci (ACF);

To(NNN)

crypt

foci (ACF);

AaC;

MeIQx;

Aberrant hyperproliferation; Tumor plastic transformation 111. 141

Adriamycin; administration:

Liposome; Antitumor

cancer;

Gastric

Uterine

cancer:

cervical

carcinogenesis

Calibration 111. 199

Mammary

agent;

Polyethyleneglycol; 111.71

neo-

Antioxidant

Intraperitoneal

Cancer promotion; Acetylaminofluorene Cancer;

cytometry;

Medium-term form (GST-P): 111. IS

Carcinogenesis; Tobacco; 4-(Methylnitrosamino)-I-(Spyridyi)-l I67

Amplification: Progression

K-ras;

Catalase: oxidation;

agent;

Ceramide; Protein phosphatase-2A; D3; Head and neck cancer 111, 87

Intrap-

Chemoprophylaxis; methylurea; Mammary

Antioxidant Adriamycin:

enzymes; Apoptosis; Genes 111, 225

Antitumor; Liposome: eritoneal administration

Polyethyleneglycol; Ill, 77

c-myc;

Chemotherapeutic

Adriamycin;

111, 39

Mink:

Amplification:

Tumour

cells

Hepatocarc~nogenesjis;

1.

Serum insuhn

ALA; Hyperthermia; Laser; Liver tumour; Photodynamic therapy: Photosensitiser, Scanning electron microscopy; Vasculature 111, IS7 Renal clear cell adenocarcinoma; 111. I27

K-ray;

n2 MRiLKP;

EGF rweptor; 111. 149

Fatty acid composition;

Captafol; I.-Cysteine; transferase placental antigen (PCNA); Rat

LXXX

MCF-7: MCF- I OA: u-Tocopheroi hemisuccinate II I, 133

Colon

Flow

Antioxidant

111. 7 I

‘Tamoxifen

c-myc: Renal clear cell ndenocnrcinoma: Progression 111, 127 beads;

Polymorphism;

Photosensitizer:

cancer

N-Acetyltransfcrase;

Breast epithelial cells: hemisuccinatc; Cholesteryl

mouse:

Adriamycm;

carcinogenesis

inhibitors:

Adriamycin; Apoptosis; Chemotherapeutic enzymes; Genes 111, 32s

mRNA;

agent;

Colon

111. 10s Aberrant 111. 105

Fluorescence;

Min

111, i79

bioassay. Glutathione .F Proliferating cell nuclear

N’-Nitmsonomicotine (NNN): -hulanone (NNK) 111,

Dehydroepiandrosterone Enzymes; Induction; Liver

sulfate: Peroxisomai Ill, 187 Invasion;

Melatonin; Tamoxifen; tumors 111, 59

Tumor:

Vitamin

N-Nitroso-N-

$

248

Subject index

Chemotherapeutic enzymes; Genes

agent; 111,225

Apoptosis;

Cholesteryl hemisuccinate; MCF-7; cells; a-Tocopherol hemisuccinate

Colorectal 111, I Cripto;

AaC;

cancer;

Growth

factor;

Cyclin-dependent Iar carcinoma Cyclosporine Cytokines; III

MelQx;

CIPl;

growth;

dbcAMP; Neuroblastoma; tion 111, 117

EGF receptor; Cancer promotion

suppression

SCID/scid

mice;

Weight

Retinoic

acid;

sulfate; Induction; Liver

Tumor

factors

Enzymes; Dehydroepiandrosterone ,f%oxidation: Induction; Liver

Midkine;

loss

111,

acid composition;

Flow cytometry; 111,199

Hemizygous deletion; APC; Polymorphism

Calibration

Gastric

Forestomach;

Squamous

cancer;

Serum insulin

cell carcinoma;

H-rcrs; ~53; N-Methyl-N-nitrosourea Gastric 111,215

cancer;

Genes; oxidant

Apoptosis; enzymes

Fluorescence;

Photosensitizer;

agent;

ClP I; WAFl

Min

Tu-

mouse;

2-Acetylaminofluorene;

; p2 1; Cyclin-dependent

ATX-S

carcinoma

suppression;

cell;

Neoplasm;

Metastasis;

Induction; Dehydroepiandrosterone ma1 poxidation; Enzymes; Liver Intraperitoneal Adriamycin;

Invasion;

Organ-

sulfate; 111, I87

Catalase;

administration; Liposome; Antitumor 111, 77

Squamous carcinoma 111, 51

mgl-I

A

Invasion; Protein phosphatase-2A; Tumor; mide; Head and neck cancer 111,87 Invasion; pathology

Tumor;

Cyclosporine

111,

111, 221 Peroxiso-

Polyethyleneglycol;

Vitamin

cell; Organ-cultured

K-ras; Renal clear cell adenocarcinoma; Progression 111, 127

111, 179 Tumour

Squamous 111, 51

Immune

Peroxisomal

(C3HxMSM)Fl

(MNU)

Chemotherapeutic 111, 225

Invasion:

Point mutations;

receptor;

acid;

activation

a2 MR/LRP;

Photosensitizer;

carcinoma; 111, I91

Histopathology; cultured skin

c-myc;

Dj;

Cera-

skin;

Histo-

Amplification;

cells 1(2)gI; 233

Fluorescence; Ill, 215

EGF 111, 149

disc; 1(2)~l; Oncogene;

2-Acetylaminofluorene;

Photodynamic

beads;

PCR-SSCP; 111, 7 1

Imaginal 233

111, 173

sulfate; Catalase; 111,187

Cancer;

cell carcinoma; (C3HxMSM)FI (MNU) 111, 97

p

111,207 Fatty

111, 67

Hyperthermia; ALA; Laser; Liver tumour; Photodynamic therapy; Photosensitiser; Scanning electron microscopy; Vasculature 111,157

Differentia-

Retinoic

gene; p53

Photosensitization;

tumors

111, 221

Catalase; Peroxisomal 111, 187

suppressor

Urological

Head and neck cancer; Protein phosphatase-2A; mor; Vitamin Dg; Ceramide 111, 87

Hepatocarcinogenesis; Cancer promotion

Immune

Midkine;

Cripto;

~21; ~53; Hepatocellu-

Hepatocarcinogenesis; 111, 149

Erythrocytes;

crypt foci (ACF)

Prognostic

factor;

H-ras; Forestomach; Squamous mouse; ~53; N-Methyl-N-nitrosourea

111.67

WAFl;

Differentiation; Neuroblastoma; dbcAMP 111, 117 Dog; Osteosarcoma;

Growth

Hepatocellular kinase; p53

A; Metastasis;

Dehydroepiandrosterone oxidation; Enzymes;

Breast epithelial

Aberrant

tumors

Glutathione S-transferase placental form (GST-P); Captafol; LCysteine; Medium-term bioassay; Proliferating cell nuclear antigen (PCNA); Rat 111, 15

~53; Hepatocellular

Recurrence;

Urological

kinase; 111, 191

Tumor

kinase;

nm23 gene;

Antioxidant

MCF-1OA; 111, 133

CIPl; WAFl; ~21; Cyclin-dependent carcinoma 111. 191 Colon carcinogenesis; 111.105

Adriamycin;

Oncogene;

Neoplasm;

Imaginal

disc; Tumor;

mgl-1

111,

10; Laser

mouse;

L-Cysteine; Captafol; transferase placental antigen (PCNA); Rat

Medium-term form (GST-P); 111, 15

bioassay; Glutathione SProliferating cell nuclear

Ill.97 ATX-SIO;

Laser

Adriamycin;

Anti-

Laser; ALA; Hyperthermia; Liver tumour; Photodynamic therapy; Photosensitiser; Scanning electron microscopy; Vasculature 111, 157 Laser; Fluorescence; 111,215

Gastric

cancer;

Photosensitizer;

ATX-SIO

Liposome; ministration;

Polyethyleneglycol; Adriamycin; Antitumor 111, 77

lntraperitoneal

ad-

Liver tumour; ALA; Hyperthermia: Laser; Photodynamrc therapy; Photosensitiser; Scanning electron microscopy; Vasculature Ill. 157 Liver; Dehydroepiandrosterone oxidation; Enzymes; Induction Macrophage:

Tumor

necrosis

Mammary neoplastie non; Tumor inhibitors Mammary tumors; N-Nitroso-N-methylurea

sulfate; Catalasc; 111, I87 factor-a;

Tumor

transformation; 111. 141

Peroxisomal

hyperprolifera-

nm23 gene; 111, 1

acid;

Oncogene; 233 Organ-cultured Histopathology

MCF-7; Breast epithelinl Cholesteryl hemisuccinate

cells; rx-Tocopherol 111. 133

Osteosarcoma;

MCF-7; MCF- I OA: Breast epithelinl hemisuccinate. Cholesteryl hemisuccinate

cells; a-Tocopherol 111. 133

Medium-term bioassay; Captafol; transferase placental form (GST-P); antigen (PCNA); Rat 111. 15 MeIQx; ArtC; 111. 105

Aherrant

crypt

Melatonin: methylurea:

Chemoprophylaxis; Mammary tumors

Metastasis;

Cyclosporine

t-Cysteine; Glutathione SProliferating cell nuclear

foci (ACF));

Colon

A; Immune

suppression

Oncogene;

Neoplasm;

lmaginal

Midkine; Neuroblastoma; tion 111, II7

Retinoic

m&-l; 233

/(2)x/.

Min mouse; PCR-SSCP; Point Hemizygous deletion 111, 71

mutations;

Mink; Tobacco, Carcinogenesis; 4-(Methylnitrosnmino)I -(3-pyridyl)I 67 mRNA;

Basrc FGF; Utenne

A”-Nitrosonornicotine 4-( Methylnitrosnmino)I67

ccrvrcal

APC:

Ri-Methyl-N-nitrosourea carcinoma; (C3HxMSM)Fl

tumors

(MNU); Forestomach: mouse; H-rus; pS3 Chemoprophylaxrs; 111. 59

1(21al: Neoplasm;

skin; Squamow 111, S I Dog; Tumor

inhibrtion:

Imnginal

carcinom:r

~53; CIPI; carcinoma

kinase:

WAFl; ~21: Cyclin-dependent 111, 191

~53. Dog; Osteoaarcoma:

Tumor

Photosensitization.

Differentia-

Polymorphism:

APC;

Polymorphism;

sulfate:

Erythrocyte~

Photosensitiser; ALA; Hyperthermia; Laser; Liver- tumour; Pnotodynamic therapy: Scanning electron microscopy: Vasculaturc 111.157

Photosensitizer; 111.215

Erythrocytes:

Fluorescence:

Photodynnnnc

Gastric

Point mutations; PCR-SSCP: Mm Hemizygous deletion 111, 7 I

111, 39

111, L73

Photodynamic therapy; ALA. Hypcrthermid, Laser: Lrver tumour, Photosensitiser: Scanning electron microscopy; Vancu!ature 111, IS7

Photosensitization; 111. X)7 Mink; 111.

asion.

(C3HxMSM)FL t 11. 97

Photodynamic 111.20?

activation;

In\

111. I7 i

carcinoma; (h4NU) mouse;

111.

Hepatoceliular

gene

Dehydrocpiandrostcrone Liver 111, 1X?

111.

Point mutations; Min deletion II 1. 7 I

rrr,gl- i

p53: Hepatoceiiuku

kinaae.

suppressor

factors

c:ctl;

gene; pS1

~21; CIP I; WAFI; Cyclin-dependent carcinoma 111, i91

Differemia.

Radioprotection

drac; Tumor:

suppressor

111,

Prognostic

Peroxisomal ~oxidatiin; Catalase: Enzymes: Induction:

111.21

Breast cancer: Tnmoxifcn

Recurrence;

acrd; ‘Tumor

m&i

dhcAMP;

111, 221

N’-Nitrosonornicotine (NNN); I -hutanone (NNK) 111,

cancer

Ursolic

cancer;

acid;

PCR-SSCP; Hemizygous

disc: Tumor

dbcAMP:

Retinoic

disc; Tumor;

N-Nitroso-N-

(NNN); Tobacco; Carcinogenesis; I -(3-pyridyl) 1-hutanonc (NNK)

N-Acetyitransferase;

A’-Nitroso-N-methylurea: moxifen; Mammary

acid;

Midkine;

Imaginal

~53; Forestomach: Squamous cell mouse; H-rus; N-Methyl-N-nitrosourea

carcinogen&s

Tamoxifen; 111, 59

Oncogene;

Colorectal

Tnmoxifen;

MCF-1OA; hemisuccinate;

Melatonin;

I(2)&

Neuroblastoma; tion 111. 117

Oleanolic 111.7

111, 27

Aberrant

Chemoprophylaxis; 111, 59

,9

Neoplasm: 233

cancer.

mouse:

acrivation

,A TX-SiO.

Laser

APC:: Polymorphism.

Squamous 111, 97

cell

Polyethyleneglycol; Lrposornc: Adriamycm: administration; Antitumor 111. 77

Melatonin:

Tn-

Polymorphism; PCR-SSCP: Pomt mutations, Hemizygous deletion 111. 7 I

Intraperitonenl

Min

mouse:

APC:

250

Subject index

Prognostic

factors;

nm23 gene;

Colorectal

cancer;

Recurrence

111, I Progression; Amplification

Renal clear 111, 127

cell

adenocarcinoma;

c-myc;

K-ras;

Proliferating cell nuclear antigen (PCNA); Captafol; Cysteine; Medium-term bioassay; Glutathione S-transferase cental form (GST-P); Rat 111, 15 Protein phosphatase-2A; Invasion; Tumor; mide; Head and neck cancer 111, 87 Radioprotection; 111.7

Oleanolic

acid; Ursolic

Rat; Captafol; L-Cysteine; Medium-term transferase placental form (GST-P); antigen (PCNA) 111, 15 Recurrence: 111, I

nm23 gene;

Renal clear Progression

Colorectal

Neuroblastoma;

bioassay; Proliferating

c-myc;

Midkine;

D3; Cera-

acid; Tumor

cancer;

cell adenocarcinoma; 111, 127

Retinoic acid; tion 111, II7

Vitamin

inhibition

Glutathione Scell nuclear

Prognostic

K-ras;

Serum

mice;

insulin;

Squamous pathology

Tumor

Cancer;

carcinoma 111, 51

growth;

dbcAMP;

Cytokines;

Weight

Fatty acid composition cell; Invasion;

Organ-cultured

factors

Amplification;

Differentia-

Scanning electron microscopy; ALA; Hyperthermia; Liver tumour; Photodynamic therapy; Photosensitiser; ture 111, IS7 SCIDkcid III

L-

pla-

Laser; Vascula-

loss

111,

111, 179 skin; Histo-

Squamous cell carcinoma; Forestomach; (C3HxMSM)Fl mouse; H-~I.F; ~53; N-Methyl-N-nitrosourea (MNU) 111, 97 Tamoxifen; methylurea:

Chemoprophylaxis; Mammary tumors

Tamoxifen;

N-Acetyltransferase;

Melatonin; 111, 59 Breast cancer

N-Nitroso-N-

111, 39

Tobacco; Carcinogenesis; Mink; 4-(Methylnitrosamino)-I-(3.pyridyl)-1-butanone 167 Tumor 111

growth;

Cytokines;

Tumor 111,7

inhibition;

Tumor

necrosis

Tumor

suppressor

Tumor; 233

i(2),&

mice;

acid; Ursolic

Weight

Macrophage;

Neoplasm;

Tumor

Tumor

necrosis

Tumour cells; Flow 111, 199 Urological

tumors;

Ursolic 111,7

acid;

Uterine

cervical

factor-a;

lmaginal

Cripto;

Oleanolic

Basic FGF;

Hyperthermia; Photosensitiser;

Weight III

loss; Tumor

growth;

D3; Cera-

a2

MR/LRP

111. 67

inhibition;

mRNA

Radioprotection

111, 21

Laser; Liver tumour; PhoScanning electron micros-

Vitamin D3; Protein phosphatase-2A; mide; Head and neck cancer 111, 87 WAFl; CIPI; ~21; Cyclin-dependent carcinoma 111, 191

111,

111, 27 beads;

factor

acid; Tumor

cancer;

Vasculature; ALA; todynamic therapy; copy 111, IS7

Growth

111. 173

Vitamin

Calibration

neo-

disc; rn~I-1

Macrophage

cytometry;

111,

111, 27 ~53

Tumor; Protein phosphatase-2A; Invasion; mide; Head and neck cancer 111, 87 Tumor;

loss

Mammary

gene; Dog; Osteosarcoma;

Oncogene;

111,

acid; Radioprotection

Aberrant hyperproliferation; 111, 141

factor-a;

(NNN); (NNK)

SCIDlscid

Oleanolic

Tumor inhibitors; plastic transformation

N’-Nitrosonomicotine

Invasion;

kinase;

Cytokines;

Tumor;

Cera-

~53; Hepatocellular

SCID/scid

mice

111,